Routine Blood Test Improves Melanoma Disease Monitoring

by Bidita Debnath on  June 28, 2015 at 8:45 PM Research News   - G J E 4
Study conducted at QIMR Berghofer Medical Research Institute has found that new markers for melanoma may allow the disease to be accurately monitored via a routine blood test.
 Routine Blood Test Improves Melanoma Disease Monitoring
Routine Blood Test Improves Melanoma Disease Monitoring

Researchers said that the new biomarkers could be ideally suited for monitoring tumor progression in patients diagnosed with early metastatic disease.

This panel of markers could be useful in tracking melanoma progression or recurrence in patients being monitored by their treating clinician as they are highly sensitive and specific and are significantly better than markers currently being used.

Better monitoring may improve a patient's chance of survival by detecting melanoma progression before metastatic disease is clinically evident and allowing treatment to start sooner.

The blood test would look for elevated levels of the markers, or microRNAs, tiny molecules which regulate the amount of protein a gene can produce. In specimens from stage IV patients, the new biomarkers confirmed tumor progression in 100% of cases, Stark said.

Queensland Science Minister Leeanne Enoch said the research represents a significant advance for melanoma patients, adding that the ability to identify signs of melanoma progression sooner will be a valuable clinical tool. The research has been published in EBioMedicine.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like